XML 38 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure        
Net income (loss) attributable to Arrowhead Pharmaceuticals, Inc. $ 370,445 $ (125,300) $ 197,360 $ (258,164)